PHENOMIN-CIPHE Centre d'Immunophénomique

Services:

Mouse and cell line genetic engineering
High content standardised immunophenotyping
Single cell -omics technologies
Advanced data analysis
Breeding & cohort delivery (SOPF, EOPS)
Rederivation and cryopreservation
BSL2 and BSL3 animal facility
Preclinical disease models

Address:
163 Avenue de Luminy, case 936
13288 Marseille cedex 09
France

Web: https://ciphe.marseille.inserm.fr

Contact person:
Dr Bernard Malissen
Head of PHENOMIN-CIPHE

The Centre of Immuno-Phenogenomics is an advanced technological centre dedicated to service deliveries and research collaborations that operates under the administrative authority of INSERM, CNRS and Aix-Marseille University. CIPHE is one of the founding members of PHENOMIN, the French infrastructure for Phenogenomics together with ICS (Strasbourg), TAAM (Orléans) and the cluster Marseille Immunopole (MI).

PHENOMIN-CIPHE provides academic and industrial partners with customised preclinical mouse and cell line model generation, high-content standardised flow, spectral and mass multiparametric immunophenotyping, single cell -omics studies and advanced data analysis of the mouse and human immune systems under normal and pathological conditions (inflammation, infection, cancer).

CIPHE participates in several French and international research programs (ERC, ANR, INCA, ARSEP, In- vestissements d’Avenir Program Labex, Equipex, IMPC, Immgen) that focus on immunology, inflammation, infection and cancer.

Matching News

Scientific Publication July 24, 2023

New INFRAFRONTIER Article Published in Journal Mammalian Genome

A new publication of INFRAFRONTIER in Mammalian Genome is available on line now. Get an overview of the latest INFRAFRONTIER advancements, including services, resources, and technical developments.

General May 21, 2021

Record participation in COVID-19 Open Call – five projects selected

The interest in the scientific community to fight the pandemic using mouse models is remarkably high. In December 2020, INFRAFONTIER launched an attractive free-of-charge service for the biomedical research community fighting against the COVID-19 pandemic: The COVID-19 Therapeutics Pipeline Trans-national Access (TA) Call offered academic researchers to test their novel therapeutics and vaccine candidates in a preclinical Bio-Safety Level 3 (BSL3) pipeline using COVID-19 optimized mouse models

Training March 19, 2019

Phenomin invites biomedical researchers from all over Europe to its Advanced School for Mouse Phenogenomics, 20 – 24 May 2019

It´s a unique training event for of all kinds of biomedial scientists working with mouse models – held in a fascinating location: The bi-annually organized European Advanced School for Mouse Phenogenomics, taking place on 20 to 24 May 2019 near Strasbourg, offers an overview of up-to-date methods and good practices for the use of mouse models in scientific research that cannot be found anywhere else in Europe.

Training September 12, 2016

Upcoming Training Courses in Mouse Phenogenomics at phenomin

Strasbourg, France, 2016 November 09th-10th –In vivo CRISPR-Cas9 genome editingNEW!
Strasbourg, France, 2016 November 23th-25th –Primary phenotyping of mouse embryos
Strasbourg, France, 2017,March 14th-17th –Mouse models for diseases: approaches in phenotyping
Goersdorf, France, 2017, June 12th-16th– 2d advanced European school in mouse phenogenomics

General December 5, 2013

France, Greece, Czech Republic and Finland enter the INFRAFRONTIER GmbH

In a formal act authenticated by a notary in Munich, four founding members acquired shares of the INFRAFRONTIER GmbH: the Centre National de la Recherche Scientifique (CNRS) from France, the Biomedical Sciences Research Center ‘Alexander Fleming’ from Greece, the Institute of Molecular Genetics of the Acedemy of Sciences of the Czech Republic, and the University of Oulu in Finland.